Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 38

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

335

HTML

3331

Figures (1-2)

180

Tables (1-3)

177

Sum=4023

Oct 14, 2012 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 14, 2012; 18(38): 5412-5417
Published online Oct 14, 2012. doi: 10.3748/wjg.v18.i38.5412

Table 3 Outcomes of endoscopic argon plasma coagulation treatment (n = 21)

Median duration of follow up (mo)	36 (6-120)
Median time required for treatment (min)	15 (10-36)
Median number of treatment sessions(times)	2 (1-4)
Median duration of hospitalization (d)	14 (5-68)
Complications
Postoperative bleeding	0
Perforation	0
Residual tumor and recurrence	2 (9.5%)

Citation: Tahara K, Tanabe S, Ishido K, Higuchi K, Sasaki T, Katada C, Azuma M, Nakatani K, Naruke A, Kim M, Koizumi W. Argon plasma coagulation for superficial esophageal squamous-cell carcinoma in high-risk patients. World J Gastroenterol 2012; 18(38): 5412-5417
URL: https://www.wjgnet.com/1007-9327/full/v18/i38/5412.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i38.5412